Article metrics

Original research
Safety of immune checkpoint inhibitor rechallenge after discontinuation for grade ≥2 immune-related adverse events in patients with cancer

 

Online download statistics by month:

Online download statistics by month: December 2020 to May 2024

AbstractFullPdf
Dec 202030830891
Jan 2021295295189
Feb 202117317399
Mar 202118118182
Apr 202111011073
May 202112212252
Jun 202113213269
Jul 2021757555
Aug 2021888849
Sep 2021737335
Oct 202113913998
Nov 202111811898
Dec 202113513564
Jan 2022878860
Feb 2022636849
Mar 202212212372
Apr 202212913053
May 202213613982
Jun 202212412789
Jul 202211411781
Aug 20229910283
Sep 202210110564
Oct 2022114118106
Nov 2022707039
Dec 202213713961
Jan 202315015070
Feb 202311611657
Mar 202313313573
Apr 2023767750
May 202311311457
Jun 202310210459
Jul 2023777741
Aug 2023636734
Sep 2023969640
Oct 202312812830
Nov 202316216245
Dec 2023545628
Jan 2024525329
Feb 2024646441
Mar 2024868766
Apr 2024777743
May 2024666744
Total486049052700